|
Market Cap (24-Jun) $29,889,572 (1,428th) |
Close (30-Jun) $0.030 |
Volume (30-Jun) 960,646 |
Shortsold (12-Dec) 10,096 (0.00%) (692nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS 0 |
LBT released this announcement to the ASX on 9 January 2023, 8:49. The announcement is marked as price sensitive, and is 2 page(s) in length and 117.2kb in size.
You can view all announcements from LBT and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from LBT | |
|---|---|
| APAS Presented at ASM Conference | 20 June 2023, 10:07 |
| APAS Compact Extension to Project Funding Timeframe | 20 June 2023, 10:06 |
| Notice under Section 708A - Cleansing Notice | 2 June 2023, 9:56 |
| AstraZeneca Partners LBT for APAS Pharma Development | 9 January 2023, 8:49 |
| Release from Escrow | 3 January 2023, 10:00 |
| LBT Strengthens APAS Pharma Development | 20 December 2022, 8:56 |
| CCS Appoint Thermo Fisher as Exclusive European Distributor | 19 December 2022, 9:04 |
You must be logged in to post a reply.
LBT Innovations 